The subcutaneous tumour showed approximately 100–1000-fold higher IFN-α levels than the serum did (Figure 2), confirming a markedly increased IFN-α concentration in the subcutaneous tumour with little leakage into the serum (Hatanaka et al, 2004). The gene discussed is IFNA1; the disease is neoplasm.